QNCX vs ROP · $79.3M cap vs P/E 41, rev $4.20B
Quince Therapeutics, Inc. (QNCX) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
QNCX does not have a complete income-statement cache yet.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
QNCX currently screens at market cap $79.3M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the QNCX and ROP stock pages for the full models.
Not investment advice.